Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy
HR
2
1
0,5
1 2 3 4
No lipid-lowering medicationLipid-lowering medication
Van de Woestijne et al., JACC 2013
Risk for all vascular events across HDL-c quartiles, with/without intensive lipid-lowering therapy
1 2 3 4
HR
0,5
2
1
No intensive lipid-lowering therapyIntensive lipid-lowering therapy
Van de Woestijne et al., JACC 2013